pruritus hiemalis
Conditions
Interventions
Control Group:mometasone furoate 0.1% cream once daily
Sponsors
Rui Jin Hospital, Shanghai Jiao Tong University School of Medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Clinically Diagnosed pruritus hiemalis patients; 2. No age limitation; 3. No limitation on gender; 4. Participant or legal guardian fully understands the content of the clinical trial, is willing to attend the research voluntary andsign the informed consent form; 5. Physical examination is qualified, participant does not have previous severe systemic disease.
Exclusion criteria
Exclusion criteria: 1. other skin diseases; 2. physical examination failed to qualify for enrollment; 3. during gestational andlactation period; 4. known allergic history toward drug or moisturizer under study; 5. involved in any other clinical trial three months before enrollment; 6. frequently usage of herbal, hypnotics, sedative, stabilizers, or other addictive medication; 7. alcoholics, psychotic, or participants who cannot follow prescription order; 8. Utilization of any types of skin moisturizers or topical medications within one-month prior to the screening andduring the study period; 9. systemic therapies or phototherapy previously within three months of screening andduring the study period.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| dryness;Pruritus; | — |
Secondary
| Measure | Time frame |
|---|---|
| skin capacitance;skin transepidermal water loss; | — |
Countries
China
Contacts
Public ContactJie Zheng
Outcome results
None listed